Please use this identifier to cite or link to this item:
|Title:||Oncogenic potential of the RUNX gene family: 'Overview'||Authors:||Ito, Y.||Keywords:||Developmental regulator
Heterodimeric transcription factor
Leukemia, gastric cancer
|Issue Date:||24-May-2004||Citation:||Ito, Y. (2004-05-24). Oncogenic potential of the RUNX gene family: 'Overview'. Oncogene 23 (24) : 4198-4208. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.onc.1207755||Abstract:||Runt-related (RUNX) gene family is composed of three members, RUNX1/AML1, RUNX2 and RUNX3, and encodes the DNA-binding (α) subunits of the Runt domain transcription factor polyomavirus enhancer-binding protein 2 (PEBP2)/core-binding factor (CBF), which is a heterodimeric transcription factor. RUNX1 is most frequently involved in human acute leukemia. RUNX2 shows oncogenic potential in mouse experimental system. RUNX3 is a strong candidate as a gastric cancer tumor suppressor. The β subunit gene of PEBP2/CBF is also frequently involved in chromosome rearrangements associated with human leukemia. In this Overview, I will summarize how this growing field has been formed and what are the challenging new frontiers for better understanding of the oncogenic potential of this gene family.||Source Title:||Oncogene||URI:||http://scholarbank.nus.edu.sg/handle/10635/133028||ISSN:||09509232||DOI:||10.1038/sj.onc.1207755|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.